Offer - Urjas Oil for just ₹ 1 X
Imatib 400 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Chronic Myelogenous Leukemia are some of its major therapeutic uses. Secondary and off-label uses of Imatib 400 Mg Tablet have also been mentioned below.
The right dosage of Imatib 400 Mg Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Imatib 400 Mg Tablet have been listed ahead. Normally, these side effects of Imatib 400 Mg Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Imatib 400 Mg Tablet is Severe for pregnant women and Moderate for women who are breastfeeding. Further, the section on Imatib 400 Mg Tablet related warnings talks about Imatib 400 Mg Tablet's effects on the liver, heart and kidney.
The section on Imatib 400 Mg Tablet contraindications lists all such conditions.
Drug reaction of Imatib 400 Mg Tablet with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Imatib 400 Mg Tablet is not safe while driving, and is is not addictive in nature.
Imatib 400 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Imatib 400 Mg Tablet safe for pregnant women?
Imatib should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Imatib 400 Mg Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Imatib. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Imatib 400 Mg Tablet on the Kidneys?
Kidney can be affected by Imatib. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Imatib 400 Mg Tablet on the Liver?
Imatib may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Imatib 400 Mg Tablet on the Heart?
Imatib may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Imatib 400 Mg Tablet unless your doctor advises you to do so -
Is this Imatib 400 Mg Tablet habit forming or addictive?
Forming a habit of Imatib 400 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Imatib 400 Mg Tablet. So it is best to avoid driving.
Is it safe?
Imatib 400 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Imatib 400 Mg Tablet in mental disorders is not effective.
Interaction between Food and Imatib 400 Mg Tablet
Taking Imatib 400 Mg Tablet with food does not harm your health.
Interaction between Alcohol and Imatib 400 Mg Tablet
Due to lack of research, there is no information about the side effects of taking Imatib 400 Mg Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gleevec (imatinib mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 674-676
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869